Business
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF ) (“Crescita” or th...
About this update from Crescita Therapeutics, Inc.
[{"type":"text","content":"Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwleftsingle { border-left: solid black 1pt }\n.bwpadb4 { padding-bottom: 5px }\n.bwpadl0 { padding-left: 0px }\n.bwpadr0 { padding-right: 0px }\n.bwrightsingle { border-right: solid black 1pt }\n.bwrowaltcolor1 { background-color: #d3d3d3 }\n.bwsinglebottom { border-bottom: solid black 1pt }\n.bwtablemarginb { margin-bottom: 10px }\n.bwtopsingle { border-top: solid black 1pt }\n.bwvertalignb { vertical-align: bottom }\n.bwvertalignm { vertical-align: middle }\n.bwwidth100 { width: 100% }\n.bwwidth15 { width: 15% }\n.bwwidth40 { width: 40% }\n \n\n\n\n Crescita Therapeutics Inc. (\n \n TSX: CTX\n \n and\n \n OTC US: CRRTF\n \n ) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its Annual General and Special Meeting of Shareholders held at its corporate headquarters in Laval, Quebec on June 4, 2025. The detailed results of the votes received by proxy are as follows:\n \n\n\n Election of Directors\n \n\n\n\n\n\n\n Director Nominees\n \n\n\n\n\n\n NUMBER OF SHARES\n \n\n\n\n\n\n PERCENTAGE OF VOTES CAST\n \n\n\n\n\n\n\n\n FOR\n \n\n\n\n\n\n WITHHELD\n \n\n\n\n\n\n FOR\n \n\n\n\n\n\n WITHHELD\n \n\n\n\n\n\n\n Daniel N. Chicoine\n \n\n\n\n 5,432,232\n \n\n\n\n 301,172\n \n\n\n\n 94.75%\n \n\n\n\n 5.25%\n \n\n\n\n\n\n Anthony E. Dobranowski\n \n\n\n\n 5,455,219\n \n\n\n\n 278,185\n \n\n\n\n 95.15%\n \n\n\n\n 4.85%\n \n\n\n\n\n\n John C. London\n \n\n\n\n 5,427,266\n \n\n\n\n 306,138\n \n\n\n\n 94.66%\n \n\n\n\n 5.34%\n \n\n\n\n\n\n Deborah Shannon-Trudeau\n \n\n\n\n 5,463,225\n \n\n\n\n 270,179\n \n\n\n\n 95.29%\n \n\n\n\n 4.71%\n \n\n\n\n\n\n Serge Verreault\n \n\n\n\n 5,490,982\n \n\n\n\n 242,422\n \n\n\n\n 95.77%\n \n\n\n\n 4.23%\n \n\n\n\n\n\n Reappointment of External Auditors\n \n\n\n\n\n\n\n Outcome\n \n\n\n\n\n\n NUMBER OF SHARES\n \n\n\n\n\n\n PERCENTAGE OF VOTES CAST\n \n\n\n\n\n\n\n\n FOR\n \n\n\n\n\n\n WITHHELD\n \n\n\n\n\n\n FOR\n \n\n\n\n\n\n WITHHELD\n \n\n\n\n\n\n\n Ernst & Young LLP reappointed\n \n\n\n\n 6,3...